Is XXXX after cardiac surgery due to cardiopulmonary bypass?

@entity1 @entity460 @entity12828 @entity1011
Although @entity12828 has been reported in a large proportion of @entity1 undergoing cardiac surgery with cardiopulmonary bypass, its clinical significance and pathogenetic mechanisms remain poorly understood. The study was designed to investigate whether avoidance of cardiopulmonary bypass would limit amylase elevation. Serum levels of amylase and lipase were measured preoperatively as well as 24 and 48 hours postoperatively in 58 @entity1 undergoing elective coronary artery bypass grafting. Three surgical approaches were used: cardiopulmonary bypass (n = 32) and off-pump through a median sternotomy (n = 14) or a left minithoracotomy (n = 12). There was no hospital mortality or postoperative abdominal complications. Transient @entity12828 occurred in 14 @entity1 : 7 (22%), 5 (36%), and 2 (17%) in the respective groups. The increase in amylase levels was similar among the groups. However, no lipase elevation was detected in any @entity1 . There was no clear correlation between @entity12828 and increased @entity1011 levels. Perioperative plasma @entity460 levels were normal in @entity1 who had @entity12828 . Our results indicate that @entity12828 after bypass surgery is not related to the use of cardiopulmonary bypass or the mode of surgical access.
